Elderly
Introduction
The EUROCARE I and II studies, at the time of their publication the largest population-based studies investigating cancer survival in Europe, revealed important geographical variations in survival among European countries for all cancer sites [1, 2] . The variation was, however, different in younger and older patients, depending on the general prognosis of each cancer [3] . In addition, very large and unexpected differences in survival between the elderly and younger adults were observed. Elderly patients, those aged 65 years or over, had much poorer survival rates than younger adults, particularly at one year after diagnosis. The relative disadvantage of elderly patients was more noticeable in women generally and for gynaecological cancers in particular [4, 5] .
These findings suggest a possible role played by stage of disease at presentation and the importance of social support as well as access to health care, all of which are strongly influenced by socio-economic factors. Influential experts in geriatric oncology consider that large systematic studies are warranted in two important areas: clinical response to cancer treatment in the presence of the normal physiological ageing process and co-morbidities; and the psychological resources and socio-economic support used by the elderly to cope with the effects of cancer and its treatment [6] .
Very marked ecological correlations have been observed between some socio-economic factors and survival for patients of all ages combined for various cancers [3] . Other studies however, did not find a link between socio-economic factors and health outcomes in the elderly [7] [8] [9] . These contradictory results probably arise from the differences in the indicators used to measure health outcomes [10] .
The ELDCARE project is an ecological study specifically planned to describe and understand the relationships between cancer survival in the elderly and both socio-economic conditions and the characteristics of health care systems in a large number of European countries.
The basis and the main features of this project have been described in a previous publication [11] . That paper focused on the description of the database and on the analysis of the relationships between cancer survival and various characteristics of the health systems in different countries. The present paper examines the relationships between cancer survival and socio-economic factors for 11 major cancers.
Patients and methods
Incidence and follow-up data, used for computing survival rates, were obtained from EUROCARE 3, the largest study ever carried out to investigate cancer survival in Europe [12] . For our study, only elderly patients, those aged from 65 to 84 years, were considered. This choice of age range was intended to help overcome some of the well known problems with statistics in the very elderly, which are often not reliable due to the lower completeness and poorer quality of collection and registration [5, 13] . The incidence data for cancers of the stomach, colon, rectum, lung, melanoma, breast, cervix and corpus uteri, ovary and prostate, and non-Hodgkin's lymphoma (NHL) related to 657,541 elderly subjects diagnosed during the period 1990-1994. Patients were followed up for at least five years in order to assess their vital status. Those patients recorded by the cancer registries (CRs) only through information from a death certificate (DCO cases) were excluded from the survival analysis. Information from death certificates mentioning cancer is used by CRs as a basis for ''tracing back'' (in time) and ascertaining cases previously not registered. Such cases tend to have shorter survival than average (because they died from cancer rather than an ''other'' cause). Death certificate information was not routinely available to the registries in France, The Netherlands and Sweden. This should be recognised as a potential cause of bias, affecting particularly the oldest age groups and should be taken into account when comparing survival rates for these three countries with those of other countries. Data were collected by 53 CRs in 19 European countries (Denmark, Finland, Iceland, Norway and Sweden in Northern Europe; United Kingdom; Austria, France, Germany, Switzerland and The Netherlands in Western Europe; Italy, Portugal and Spain in Southern Europe; Czech Republic, Estonia, Poland, Slovakia and Slovenia in Eastern Europe). Survival rates for the United Kingdom were calculated from the pooled data for England, Scotland and Wales. Table 1a, for men, and Tables 1b, 1c for women, show the numbers of cases and the relative survival at five years from diagnosis by country.
Observed and relative survival were computed using Hakulinen's methods [14] . Survival for each European country was taken to be the value for the national CR where one existed, otherwise the figure for the pool of participating CRs in that country was used.
The second part of the material comprises socio-economic variables and characteristics of the national health care systems. A representative for each participating country provided data at the ecological level, relating to the whole nation, through collection of information from national statistics offices and other official national or international sources.
In this way, we covered several aspects of the socioeconomic field with a wide array of variables; only a few of these factors were chosen for inclusion in the current analysis. The selection procedures, and the whole database, were described in a previous paper [11] . However, only a summary of the variables we used is given here.
The indicators were divided into four groups: a group with macro-economic factors (values in US dollars at Purchasing Power Parity -US$ PPP-), including gross domestic product (GDP) and total health expenditure (THE); a group including the percentages of labour force employed in agriculture, industry and services; a group with the characteristics of the national health care systems, including health employment (total health employment (TE), and total number of practitioners (TP), both per 1000 population), and medical technologies (computed tomography scanners (CTS), and equipment for nuclear magnetic resonance (ENMR), all per 1,000,000 population); and a group describing demographic factors, including marital status (proportion of population aged 65 years and older who were married and widowed) and household composition (the percentage of households with 1, 2, or 3 or more persons). The demographic indicators were taken from 1991 censuses, while all other factors related to period from 1993 to 1995.
Relative survival was correlated with socio-economic factors at the national level using Pearson's correlation (r) [15] .
Results

3.1.
Correlation between relative survival, and macro-economic factors and medical resources Table 2 gives the correlations between cancer survival at 5 years from diagnosis for patients aged from 65 to 84 years, by cancer site and sex; the variables of the macro-economic group (GDP and THE); the percentage of labour force employed in agriculture (AGR); and medical resources (CTS and ENMR, TE and TP). The correlations for GDP and THE were highly positive for nearly all the cancer sites. Most, including those for cancers of the colon, rectum, melanoma, breast, uterus, prostate and NHL were close to or above 0.70, whereas those for stomach were lower, around 0.50-0.55. The correlations for lung and ovary were much lower. There were no marked differences by sex in the correlations with GDP and THE. All the correlations between cancer survival and the percentage of labour force employed in agriculture were negative; the coefficients were mostly around À0.60 or less, but there was little or no correlation for stomach, lung, cervix uteri and ovary. For CTS and ENMR very high, positive and statistically significant correlations (from around 0.5 to 0.8) were observed for most of the cancer sites, the exceptions being lung and ovary. Unlike CTS and ENMR, the levels of equipment for radiotherapy did not show any relationship with cancer survival (data not shown). The correlations for TE were lower than for CTS and ENMR: those for four of the cancers, colon (in women), rectum, melanoma and breast, were statistically significant at around 0.5-0.65. There was no association between TP and survival for any of the 11 cancers.
3.2.
Correlation between relative survival and demographic factors Table 3 gives the correlations between the proportions of married people and cancer survival in the total population, and between the proportions of the population by marital status and cancer survival in the elderly. Almost all of the correlations between the proportion of married people in the total population and cancer survival were small and numerically negative, and none was statistically significant. The survival of elderly women was generally more strongly related to marital status than that for men. There were statistically significant correlations between the proportion of elderly married people and survival of around 0.5-0.8 for cancers of the colon, rectum, melanoma, breast and cervix in women, and for stomach and lung in men. Apart from 
RS%, relative survival (%). a Information from death certificates not available to the cancer registries (see text).
NHL, all the correlations between the proportion of elderly widowed people were negative, but only those for rectum, melanoma and breast in women were statistically significant. The correlations between the proportions of never married elderly people and cancer survival were moderate, mostly in the range 0.25-0.5 and not statistically significant; the exceptions were for breast cancer, and rectal cancer in men.
In Table 4 the correlations between the proportions of the population by household composition and cancer survival in the elderly are given. There was generally no relationship for the proportion of one person households, the exception being for melanoma in men. The correlations for the proportion of households composed of two people were generally positive, those for colon, rectum and melanoma in both sexes, and breast and corpus uteri were in the range 0.5-0.75 and statistically significant. The correlations for the proportion of households with three or more people generally exhibited a weaker and inverse pattern to that for the proportion of two person households.
3.3.
Correlation between relative survival and THE, CTS r Values are Pearson's correlation coefficients with an indication of their statistical significance ( P < 0.05, * P < 0.01). GDP, gross domestic product (per capita, US$ Purchasing Power Parity). THE, total health expenditure (per capita, US$ Purchasing Power Parity). AGR, labour force employed in agriculture per 100. CTS, number of computed tomography scanners per 1,000,000 population. ENMR, number of equipments for nuclear magnetic resonance per 1,000,000 population. TE, number of total health employment per 1000 population. TP, number of total practitioners per 1000 population. W, women, M, men. All data refer to the period 1993-1995. a Non-Hodgkin's lymphoma. the number of CTS. THE and CTS were chosen because they were variables which were generally highly related to survival and describe important aspects of the health care systems. We have included stomach, colon, breast and prostate cancers because of their high incidence in the elderly population and their positive relationships with the socio-economic indicators.
Survival for stomach was generally low, with similar values in both poor and more affluent countries; the UK and Denmark, despite their higher values of THE, had similar survival to the Eastern European countries. For colon and breast cancers the correlation with THE was stronger, but over about US$ 1600 there were only small differences in survival among the countries. There was much wider variability in survival for prostate cancer, which increased with THE up to around 80% in France and Germany, which had the highest THE values (around US$ 2000) except for Switzerland; Denmark had by far the lowest survival among Western and Northern European countries.
The number of CTS (per million population) was highly correlated with survival for all four cancer sites. For stomach and prostate cancers, the charts show a clear linear relationship, with survival rates increasing progressively from the countries with fewer than 5 CTS up to those with the highest number (around 20). For colon and breast cancers, survival generally increased only up to around 10 CTS.
Discussion
Cancer survival, macro-economic factors and medical resources
The affluence of a country, represented by GDP and THE, was very strongly related to survival in the elderly for most of the 11 major cancer sites we studied. The correlation was strong for cancers with a reasonably good prognosis in the elderly; but for cancers of the stomach and cervix uteri the association was much less strong, and no association was observed for cancers of the lung and ovary which have quite poor survival. It appears that the affluence of even the most developed European countries has little effect on survival for lung and ovary cancers, for which clinical treatment is generally not very effective. Clinical management through major surgery or complex chemotherapeutic regimens is often difficult to apply in elderly patients, who are often suffering from a heterogeneous group of co-morbid conditions and have physiological impairment [16] . For stomach and cervix uteri cancers the situation is more complex. The partial lack of correlation for stomach is due to the variation in case mix, among the European countries: the Northern countries and the UK have a subsite distribution different from the Southern countries, with a higher percentage of proximal locations (cardia and fundus) which have a poorer prognosis [17] . If we exclude these countries from the analysis, the correlation between stomach cancer survival and the independent variables would be more marked. Indeed, the low survival in affluent countries, such as the UK, The Netherlands and Scandinavian countries, is consistent with the association between high socio-economic status and tumour characteristics with adverse prognostic factors, such as advanced stage at diagnosis, cardia subsite and diffuse histology type [18, 19] . Elderly women have a high rate of under-or non-use of cervical screening and are likely to be lifelong under-utilisers, probably with a higher incidence of cervical cancer than screened women [20] . Cervical cancer has reasonably good prognosis in young women but survival quickly decreases with age. The relative risks for older women versus the middle aged of dying from cervical cancer were among the highest of all cancers, 1.8 and 1.3 at 1 and 5 years from diagnosis, respectively, with the largest disadvantage in the most elderly patients [4] . In most of the population-based studies examining early diagnosis and disease extension, cervix uteri presented more often than other cancers at an advanced stage in elderly patients. Treatment in elderly women is often less aggressive than in younger women -and the elderly are more likely to receive no treatment at all [21, 22] . Thus not only is invasive cervical cancer more common at older ages, but the survival of elderly women is worse [23] . CTS showed the strongest correlations with survival: the coefficients were similar to those for GDP and THE, and just a little higher than those for ENMR. As for the health personnel indicators, TE correlated quite well with survival, whereas TP did not. Our results are consistent with other analyses that showed, in Western countries, that GDP had a closer relationship with the number of nurses than with the number of general practitioners [24] . In some countries, such as Spain and Italy, the number of physicians (per head of population) is much higher than elsewhere, and there is an imbalance in the ratio of graduate and non-graduate staff, which is not in accordance with the recommendations of the World Bank [25] .
Cancer survival and demographic factors
Marital status played a very important role: for several cancer sites including colon, rectum and breast which have high incidence, survival was related positively with the proportion of married elderly women in the population and negatively with the proportion of widows. Marital status did not however, have the same relevance for women for all ages combined. There was a marked difference between the sexes: survival for elderly men generally did not appear to be influenced by these types of demographic factors. Demographic factors could play a major role in determining health outcomes in elderly women, by affecting access to health care and delay in diagnosis.
These results confirm our previous comparisons between cancer survival in elderly and middle aged adults. Cancer patients aged over 65 years experienced much higher risks of dying than younger adults, particularly at 1 year from diagnosis and for those cancers for which disease stage was the main prognostic determinant. Furthermore, the disadvantage of elderly women was larger than that of elderly men [4] .
Being married or widowed is for elderly people, in particular elderly women, an important factor influencing psychological status, life habits, social relationships and the use of support services offered by the community [26] . Elderly women are more likely to have a lower degree of social independence on account of, for example, having lower income and educational levels than elderly men, and to lack easy access to transport. Furthermore, they have often outlived their husbands, often have disabilities, and often need home care [27] . Large population-based studies have shown that insufficient social support is a risk factor for lower cancer survival [28] .
In the elderly, survival for several of the major cancers was related to the proportion of two person households. Two people living together would be able to provide reciprocal social support, whereas families with three or more members could be associated with relatively low affluence, and many more problems of social dependence.
One might have expected strong negative correlations between cancer survival and the percentage of families with one person, but we found generally only weak positive relationships. Unfortunately, with the available data we could not 
Conclusions
In the elderly, the correlation between GDP and survival was strong for most cancer sites. However, the countries with the highest THE did not always have the highest survival rates (particularly for breast and prostate cancers) and over a level of expenditure of around US$ 1600, survival did not improve further. Some authors have claimed that increases in THE above a fairly high threshold does not always correspond with further improvement in health performance [29] [30] [31] [32] . All European countries have been trying to provide their populations with equal access to health care, but remarkable differences still exist [33] . Countries with similar total GDP obtain better health outcomes when the distribution of income is more egalitarian [34] .
A particular role is played by factors related indirectly to social support. These observations could have remarkable consequences for health spending, because the number of elderly people is rising and they use health care services at a higher rate than young people [27] . A social network to help elderly people to cope with cancer and its therapies is becoming increasingly important, especially now that the number of elderly people living alone is also rising [34] . Suitable choices of social policy and specific health care plans should therefore be high priority in order to maintain both good health and quality of life in elderly people.
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